Bottom line
VGHAX vs XLV: the short answer
VGHAX (Vanguard Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.
XLV is cheaper at 0.08% vs 0.27% — a difference of $19 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +6.7% for VGHAX.
Updated Nov 19, 2026
VGHAX vs XLV side by side
| VGHAX | XLV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Vanguard | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.27% | 0.08% |
| Annual cost per $10k | $27 | $8 |
| 10-yr cost on $10k (prospectus) | $343 | $103 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0.02% |
| 1-yr return | +17.4% | +14.5% |
| 5-yr return (annualized) | +6.7% | +8.1% |
| 10-yr return (annualized) | +7.8% | +9.8% |
| Best quarter | — | +14.5% |
| Worst quarter | — | −12.7% |
| Net assets (fund) | $38.2B | $40.6B |
| Number of holdings | 97 | 65 |
| Portfolio turnover | 47% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of VGHAX's top 25 holdings also appear in XLV's top 25.
| Holding | VGHAX | XLV |
|---|---|---|
| Eli Lilly & Co | 8.61% | 16.51% |
| Merck & Co Inc | 5.44% | 5.52% |
| Johnson & Johnson | 4.83% | 10.64% |
| UnitedHealth Group Inc | 4.05% | 6.57% |
| Intuitive Surgical Inc | 2.52% | 2.45% |
| CVS Health Corp | 2.52% | 2.30% |
| Cencora Inc | 2.47% | 0.96% |
| Vertex Pharmaceuticals Inc | 2.36% | 2.19% |
| AbbVie Inc | 2.30% | 7.74% |
| Danaher Corp | 2.18% | 2.09% |
| Regeneron Pharmaceuticals Inc | 2.14% | 1.08% |
| Elevance Health Inc | 1.83% | 1.46% |
| HCA Healthcare Inc | 1.68% | 1.05% |
| Boston Scientific Corp | 1.53% | 1.10% |
Source: SEC Form N-PORT
VGHAX top 10
- Eli Lilly & Co — 8.61%
- Merck & Co Inc — 5.44%
- Johnson & Johnson — 4.83%
- AstraZeneca PLC — 4.59%
- UnitedHealth Group Inc — 4.05%
- Gsk Plc — 3.00%
- Edwards Lifesciences Corp — 2.56%
- Intuitive Surgical Inc — 2.52%
- CVS Health Corp — 2.52%
- Cencora Inc — 2.47%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between VGHAX and XLV?
VGHAX (Vanguard Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 0.27% — a difference of $19 a year per $10,000 invested.
Which is cheaper, VGHAX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both VGHAX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.